All Updates

All Updates

icon
Filter
Industry news
FDA approval
Remilk gains regulatory approval from the SFA and FDA
Plant-based Dairy & Egg
Feb 23, 2023
This week:
Product updates
Meta introduces Meta Credits digital currency for Horizon Worlds
Metaverse Platforms
Today
Product updates
Liquid AI launches STAR framework for AI model architecture optimization
Foundation Models
Today
Funding
9fin raises USD 50 million in Series B funding to expand US operations
Capital Markets Tech
Yesterday
Partnerships
Shastic partners with MeridianLink to provide AI workflow automation for financial institutions
Workflow Automation Platforms
Yesterday
Funding
KisoJi Biotechnology raises CAD 41 million to develop oncology candidate
AI Drug Discovery
Yesterday
M&A
Deel acquires UK money transfer startup Atlantic Money for undisclosed sum
Remote Work Infrastructure
Yesterday
Funding
Acorai raises EUR 4.2 million in funding to advance clinical studies
Next-gen Medical Devices
Yesterday
Product updates
Bosch announces Light Drive, an AR solution for all-day smart glasses
Extended Reality
Yesterday
Product updates
Partnerships
Vuzix expands OSHA collaboration; launches upgraded M400 AR smart glasses
Extended Reality
Yesterday
Product updates
StrikerVR launches pre-orders for consumer-facing Mavrik haptic VR gun
Extended Reality
Yesterday
Plant-based Dairy & Egg

Plant-based Dairy & Egg

Feb 23, 2023

Remilk gains regulatory approval from the SFA and FDA

Industry news
FDA approval

  • Remilk, an Israeli producer of plant-based dairy products through microbial fermentation, announced receiving regulatory approval from the Singapore Food Authority (SFA), as well as a “no questions” letter from the FDA.

  • The approval from the SFA will enable the sale of Remilk products in Singapore. While the company declared self-affirmed GRAS status in 2022 according to FDA protocols, the “no questions” letter from the FDA further establishes Remilk’s animal-free whey proteins as safe for consumption (following consensus from a panel of experts).

  • Analyst QuickTake: Both of these approvals are major milestones for Remilk, given that Singapore and the US are at the forefront of the alternative protein industry. Apart from the ability to sell its products, the company will be able to attract more investments and focus on R&D as regulatory approval—especially from the FDA—is seen as a variable that reduces the risk factor of a brand.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.